JP2013528060A5 - - Google Patents

Download PDF

Info

Publication number
JP2013528060A5
JP2013528060A5 JP2013514238A JP2013514238A JP2013528060A5 JP 2013528060 A5 JP2013528060 A5 JP 2013528060A5 JP 2013514238 A JP2013514238 A JP 2013514238A JP 2013514238 A JP2013514238 A JP 2013514238A JP 2013528060 A5 JP2013528060 A5 JP 2013528060A5
Authority
JP
Japan
Prior art keywords
protein
clear
visibly
nutrient liquid
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013514238A
Other languages
English (en)
Other versions
JP2013528060A (ja
JP5848756B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/039170 external-priority patent/WO2011156238A1/en
Publication of JP2013528060A publication Critical patent/JP2013528060A/ja
Publication of JP2013528060A5 publication Critical patent/JP2013528060A5/ja
Application granted granted Critical
Publication of JP5848756B2 publication Critical patent/JP5848756B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (15)

  1. カルシウムHMBおよびタンパク質を含み2.8〜4.6のpHを有し、総タンパク質の65重量%〜100重量%が可溶性タンパク質である、目に見えて清澄な栄養液体。
  2. 可溶性タンパク質が、総タンパク質の85重量%〜100重量%を表し、前記可溶性タンパク質が、ホスホセリン含有タンパク質1キログラム当たり少なくとも100ミリモルのホスホセリンを有するホスホセリン含有タンパク質を含む、請求項1に記載の目に見えて清澄な栄養液体。
  3. 可溶性タンパク質が、ホエータンパク質濃縮物、ホエータンパク質単離物、カゼイン加水分解物、加水分解コラーゲン、これらの組み合わせからなる群から選択される少なくとも1種のタンパク質を含む、請求項1に記載の目に見えて清澄な栄養液体。
  4. カルシウムHMBが、目に見えて清澄な栄養液体の0.1重量%〜5.0重量%である、請求項1に記載の目に見えて清澄な栄養液体。
  5. 目に見えて清澄な液体栄養補助食品が、脂質1.0重量%未満を含む、請求項1に記載の目に見えて清澄な栄養液体。
  6. ベータアラニン0.1重量%〜3.0重量%をさらに含む、請求項1に記載の目に見えて清澄な栄養液体。
  7. 液体が、3.1〜3.9のpHを有する、請求項1に記載の目に見えて清澄な栄養液体。
  8. ビタミンDをさらに含む、請求項1に記載の目に見えて清澄な栄養液体。
  9. カルシウムHMBおよびタンパク質を含み2.8〜4.6のpHを有し、総タンパク質の65重量%〜100重量%が可溶性タンパク質であり、カルシウムHMB対可溶性カルシウムの重量比が4.5:1〜7.3:1である、目に見えて清澄な栄養液体。
  10. 可溶性タンパク質が、総タンパク質の85重量%〜100重量%を表し、前記可溶性タンパク質が、ホスホセリン含有タンパク質1キログラム当たり少なくとも100ミリモルのホスホセリンを有するホスホセリン含有タンパク質を含む、請求項9に記載の目に見えて清澄な栄養液体。
  11. 可溶性タンパク質が、ホエータンパク質濃縮物、ホエータンパク質単離物、カゼイン加水分解物、加水分解コラーゲンおよびこれらの組み合わせからなる群から選択される少なくとも1種のタンパク質を含む、請求項9に記載の目に見えて清澄な栄養液体。
  12. 可溶性タンパク質が、目に見えて清澄な栄養液体の1重量%〜20重量%である、請求項9に記載の目に見えて清澄な栄養液体。
  13. カルシウムHMBが、目に見えて清澄な栄養液体の0.1重量%〜2.5重量%である、請求項9に記載の目に見えて清澄な栄養液体。
  14. ベータアラニン0.1重量%〜3.0重量%をさらに含む、請求項9に記載の目に見えて清澄な栄養液体。
  15. カルシウムHMB、タンパク質、イソマルツロース、ベータアラニンおよびビタミンDを含み2.8〜4.6のpHを有し、総タンパク質の65重量%〜100重量%が可溶性タンパク質であり、カルシウムHMB対可溶性カルシウムの重量比が4.5:1〜7.3:1であり、ビタミンDが最大1000IUの量で存在する、目に見えて清澄な栄養液体。
JP2013514238A 2010-06-10 2011-06-03 カルシウムhmbおよび可溶性タンパク質を含む実質的に清澄な栄養液体 Expired - Fee Related JP5848756B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35340010P 2010-06-10 2010-06-10
US61/353,400 2010-06-10
PCT/US2011/039170 WO2011156238A1 (en) 2010-06-10 2011-06-03 Substantially clear nutritional liquids comprising calcium hmb and soluble protein

Publications (3)

Publication Number Publication Date
JP2013528060A JP2013528060A (ja) 2013-07-08
JP2013528060A5 true JP2013528060A5 (ja) 2014-07-17
JP5848756B2 JP5848756B2 (ja) 2016-01-27

Family

ID=44280787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013514238A Expired - Fee Related JP5848756B2 (ja) 2010-06-10 2011-06-03 カルシウムhmbおよび可溶性タンパク質を含む実質的に清澄な栄養液体

Country Status (12)

Country Link
US (1) US9521859B2 (ja)
EP (1) EP2442676B1 (ja)
JP (1) JP5848756B2 (ja)
CN (1) CN103096736B (ja)
AR (1) AR081872A1 (ja)
BR (1) BR112012031183A2 (ja)
CA (1) CA2801339C (ja)
ES (1) ES2535389T3 (ja)
MX (1) MX2012014346A (ja)
SG (1) SG185806A1 (ja)
TW (1) TWI526161B (ja)
WO (1) WO2011156238A1 (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
WO2007075605A2 (en) 2005-12-19 2007-07-05 Abbott Laboratories Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type and type 2 cytokine production
RU2012125878A (ru) 2010-01-29 2014-03-10 Эбботт Лэборетриз Асептически упакованные питательные жидкости, содержащие бета-гидрокси-бета-метилбутират (гмб)
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
JP5892948B2 (ja) 2010-01-29 2016-03-23 アボット・ラボラトリーズAbbott Laboratories カルシウムhmbを含む栄養エマルジョン
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣hmb及可溶性蛋白質之實質上透明營養液
US9327001B2 (en) 2011-11-03 2016-05-03 University Of Florida Research Foundation, Inc. Nutritional supplement for weight management
JP5878361B2 (ja) * 2011-12-20 2016-03-08 テルモ株式会社 栄養強化用粉末食品
WO2013170189A1 (en) * 2012-05-11 2013-11-14 Abbott Laboratories Combination of beta - hydroxy - beta - methylbutyrate and beta - alanine for increasing muscle blood flow
WO2014047497A1 (en) * 2012-09-21 2014-03-27 Abbott Laboratories Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, protein and low levels of electrolytes
CN107048383A (zh) 2012-10-04 2017-08-18 雅培制药有限公司 用于增强EGCg对减缓骨骼肌损失的作用的方法
WO2014055830A1 (en) * 2012-10-04 2014-04-10 Abbott Laboratories Shelf-stable, clear liquid nutritional compositions comprising epigallocatechin gallate (egcg) and methods for preparing the same
EP2993994A4 (en) * 2013-03-14 2016-11-23 Metabolic Technologies Inc LIQUIDS AND FOODS WITH BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) IN A FREE ACID FORM
WO2015137965A1 (en) * 2014-03-14 2015-09-17 Metabolic Technologies, Inc. Liquids and foodstuffs containing beta-hydroxy-beta-methylbutyrate (hmb) in free acid form
US20140272000A1 (en) * 2013-03-14 2014-09-18 Metabolic Technologies, Inc. Liquids and Foodstuffs Containing beta-hydroxy-beta-methylbutyrate (HMB) in the Free Acid Form and Methods of Manufacturing or Producing the Same
JP2016512686A (ja) * 2013-03-15 2016-05-09 アボット・ラボラトリーズAbbott Laboratories カルシウムβ−ヒドロキシ−β−メチルブチレート、カゼインホスホペプチドおよびタンパク質を含む栄養組成物
EP2986165A1 (en) * 2013-03-15 2016-02-24 Abbott Laboratories Low calorie infant formula containing beta-hydroxy-beta-methylbutyric acid
US20160029683A1 (en) * 2013-03-15 2016-02-04 Abbott Laboratories Low calorie infant formula containing beta-hydroxy-beta-methylbutyric acid
DE102013104897A1 (de) * 2013-05-13 2014-11-13 Gelita Ag Wirkstoff zur Behandlung von Sarkopenie
US10513555B2 (en) 2013-07-04 2019-12-24 Prothena Biosciences Limited Antibody formulations and methods
US20160309770A1 (en) * 2013-12-19 2016-10-27 Abbott Laboratories Translucent, high acid, low viscosity, high caloric density nutritional composition
JP6309287B2 (ja) * 2014-01-29 2018-04-11 協和発酵バイオ株式会社 3−ヒドロキシ−3−メチル酪酸カルシウム含有飲料
US20160227828A1 (en) * 2015-02-05 2016-08-11 Abbott Laboratories Substantially clear nutritional liquids having improved sensory characteristics
EP3410874B1 (en) 2016-02-05 2021-05-05 Abbott Laboratories Whey protein based liquid nutritional composition
CN106307553A (zh) * 2016-08-11 2017-01-11 广州白云山汉方现代药业有限公司 一种含hmb的大豆肽蛋白质粉及其制备方法
US9930906B1 (en) 2017-05-05 2018-04-03 Swallow Solutions, LLC Protein beverages
CN107596356A (zh) * 2017-11-09 2018-01-19 江苏江大五棵松生物科技有限公司 一种可增加骨密度的复合胶原肽粉
WO2019158541A1 (en) * 2018-02-14 2019-08-22 Frieslandcampina Nederland B.V. Nutritional compositions for musculoskeletal support for athletes
JP2021069308A (ja) * 2019-10-30 2021-05-06 小林製薬株式会社 経口組成物
MX2022011112A (es) * 2020-03-12 2022-10-07 Abbott Lab Metodos para tratar la diarrea o afecciones inflamatorias del intestino.
EP4326091A1 (en) * 2021-04-19 2024-02-28 Abbott Laboratories High protein liquid nutritional compositions

Family Cites Families (153)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3105763A (en) 1960-03-22 1963-10-01 Beatrice Foods Co Concentrated milk
US3408210A (en) 1965-06-14 1968-10-29 Wilbert A. Heyman Dehydration of foods
US3542560A (en) 1967-12-06 1970-11-24 American Home Prod Infant formula with fat composition like human milk
GB1446965A (en) 1974-02-14 1976-08-18 Agricultural Vegetable Prod Preparation of food products
US4104290A (en) 1975-02-07 1978-08-01 H.L.S. Ltd., Industrial Engineering Company Process for separating oils and fats into liquid and solid fractions
US5219735A (en) 1980-02-01 1993-06-15 Institut National De La Recherche Agronomique Non-phosphorylated peptides from casein-based material
US4311645A (en) 1980-03-24 1982-01-19 Hoffmann-La Roche Inc. Synthesis of SRS-active compounds
US4742081A (en) 1986-01-06 1988-05-03 Alfred Stracher Carnitine coupled pharmaceutical agents
EP0367724B1 (en) 1988-10-31 1993-02-10 Sandoz Nutrition Ltd. Improvements in or relating to organic compounds
US5000975A (en) 1988-12-29 1991-03-19 American Home Products Corporation Randomized palm oil fat composition for infant formulas
CA2010511A1 (en) 1989-03-01 1990-09-01 Roberto L. Ceriani Method of enhancing cancer therapy by administration of unsaturated fatty acids
US5457130A (en) 1989-03-20 1995-10-10 Cancer Research Campaign Technology Limited Eicosapentaenoic acid used to treat cachexia
US5157022A (en) 1989-11-22 1992-10-20 Adrian Barbul Method for reducing blood cholesterol using arginine
US5028440A (en) 1990-01-30 1991-07-02 Iowa State University Research Foundation, Inc. Method of raising meat producing animals to increase lean tissue development
US5087472A (en) 1990-01-30 1992-02-11 Iowa State University Research Foundation, Inc. Feed compositions for domestics animals containing hydroxymethylbutyrate
US4992470A (en) 1990-02-08 1991-02-12 Iowa State University Research Foundation, Inc. Method of enhancing immune response of mammals
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
US5167957A (en) 1990-09-06 1992-12-01 Virginia Tech Intellectual Properties, Inc. Compositions and methods for the treatment of dietary deficiencies
US5601860A (en) 1990-11-30 1997-02-11 American Home Products Corporation Corandomized fat compositions for infant formulas
EP1787532A3 (en) 1991-01-24 2010-03-31 Martek Biosciences Corporation Microbial oil mixtures and uses thereof
KR100219771B1 (ko) 1991-03-18 1999-10-01 이치로 키타사토 돼지용 사료 및 이를 사용하는 돼지 사육법
US5171442A (en) 1991-10-18 1992-12-15 Nakshbendi Ghassan F Water purification apparatus
US5223285A (en) 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
NZ256300A (en) 1992-09-16 1997-06-24 Univ Iowa State Res Found Inc Administration of beta-hydroxy-beta-methyl butyric acid, or its convertible forms, to lower cholesterol levels
US5447732A (en) 1992-11-25 1995-09-05 Ajinomoto Co., Inc. High-absorption mineral-containing composition and foods
US5348979A (en) 1992-12-23 1994-09-20 Iowa State University Research Foundation Inc. Method of promoting nitrogen retention in humans
DE69405096T2 (de) 1993-05-13 1998-01-22 Loders Croklaan Bv Muttermilch-ersatzstoffe aus umgeestertentriglyceridmischungen
US6136858A (en) 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
US5780451A (en) 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
US5952314A (en) 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
US5444054A (en) 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5576287A (en) 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
US5726146A (en) 1994-12-06 1998-03-10 Natural Supplement Association, Incorporated Non-steroidal, anabolic dietary supplement and method to increase lean mass without linked increase fat mass
KR0140248B1 (ko) * 1995-03-23 1998-06-15 한상기 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법
US6099871A (en) 1995-06-01 2000-08-08 Bristol-Myers Squibb Company Anti-regurgitation infant formula
DE19528461A1 (de) 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
US5641531A (en) * 1995-09-28 1997-06-24 Abbott Laboratories Nutritional liquid supplement beverage and method of making same
EP1006806B1 (en) 1996-04-11 2006-09-13 Loders Croklaan B.V. Free flowing fat compositions
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US5756469A (en) 1996-07-26 1998-05-26 Beale; Paxton K. Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal
US7504376B2 (en) 1996-08-12 2009-03-17 Natural Alternatives International Methods and compositions for increasing the anaerobic working capacity in tissues
IL131126A (en) 1997-02-21 2003-04-10 Abbott Lab Compositions for reducing the incidence of necrotizing enterocolitis and the preparation thereof
US6080788A (en) 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
DE29707308U1 (de) 1997-04-23 1997-06-26 Kunz, Armin, 66450 Bexbach Präparat zur Muskelerhaltung bzw. zur Förderung des Muskelaufbaus
US6660258B1 (en) 1997-05-09 2003-12-09 Pharma Pacific Pty Ltd Oromucosal cytokine compositions and uses thereof
US6371319B2 (en) 1997-09-22 2002-04-16 Abbott Laboratories Closure system for containers
US6096358A (en) 1997-10-08 2000-08-01 Abbott Laboratories Method of manufacturing an aseptically sterilized package containing a liquid nutritional product
US6103764A (en) 1997-11-07 2000-08-15 Iowa State University Research Foundation, Inc. Method for increasing the aerobic capacity of muscle
AUPP327198A0 (en) 1998-04-30 1998-05-21 Northfield Laboratories Pty Ltd A food composition and method of using same
US6475539B1 (en) * 1998-05-07 2002-11-05 Abbott Laboratories Nutritionally complete low pH enteral formula
JP4175698B2 (ja) 1998-06-19 2008-11-05 サントリー株式会社 新規なトリグリセリド及びそれを含む組成物
US6031000A (en) 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
KR100645980B1 (ko) 1998-07-30 2006-11-14 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. 항암 활성을 갖는 약제의 제조에서 l-카르니틴 및 그의알카노일 유도체의 용도
KR20000019716A (ko) 1998-09-15 2000-04-15 박호군 바이오플라보노이드 화합물을 포함하는 혈당 강하용 조성물
US5976550A (en) 1998-11-20 1999-11-02 Engel; Peter H. Dietary food supplement
US20010008641A1 (en) 1998-11-25 2001-07-19 R. Douglas Krotzer Nutritionally active composition for bodybuilding
US6227261B1 (en) 1998-12-24 2001-05-08 Abbott Laboratories Method and apparatus for the addition of sterile liquid to an aseptic system
US6294206B1 (en) 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier
US6517775B1 (en) 1999-07-26 2003-02-11 Abbott Laboratories Sterilant monitoring assembly and apparatus and method using same
US6291525B1 (en) 1999-09-08 2001-09-18 Iowa State University Research Foundation, Inc. Method for improving a human's perception of his emotional state
MXPA02003861A (es) 1999-10-18 2003-07-14 Muscletech Res And Dev Inc Suplemento alimenticio para incrementar la masa sin desarrollar y la fuerza.
GB9929919D0 (en) * 1999-12-17 2000-02-09 Hannah Research Inst The Calcium phosphate nanoclusters and their applications
US20020006907A1 (en) 2000-02-01 2002-01-17 Paul Gardiner Alpha lipoic acid based food supplement for increasing lean muscle mass and strength
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6521591B1 (en) 2000-02-10 2003-02-18 N.V. Nutricia Pharmaceutical composition for muscular anabolism
US7250397B2 (en) 2000-02-23 2007-07-31 Zealand Pharma A/S Antiarrhythmic peptides
AU2001251449B2 (en) 2000-04-06 2005-04-07 Conlinco, Inc. Conjugated linoleic acid compositions
JP4625156B2 (ja) 2000-04-10 2011-02-02 イーエヌ大塚製薬株式会社 癌化学療法に伴う副作用軽減剤
US6420342B1 (en) 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
US20050106219A1 (en) 2000-05-30 2005-05-19 Karlheinz Bortlik Primary composition comprising a lipophilic bioactive compound
US6592878B2 (en) 2000-08-03 2003-07-15 North Carolina State University Enhancement of development of oviparous species by in ovo feeding
DK1326502T3 (da) 2000-08-29 2005-08-22 Lonza Ag Fremgangsmåde til fremstilling af en blanding, som kan granuleres, samt carnitin-magnesium-hydroxycitrat
EP1198991B1 (en) 2000-10-20 2012-12-19 Nutriz N.V: Non-dairy products derived from rice
AU2002233639B2 (en) 2001-02-15 2007-03-01 Adeka Corporation Products containing $G(b)-glucan
JP3735070B2 (ja) 2001-03-26 2006-01-11 花王株式会社 容器詰乳化飲料
US6620427B2 (en) 2001-04-24 2003-09-16 Abbott Laboratories Method for improving bone mineralization
US20030021877A1 (en) 2001-06-13 2003-01-30 Cain Frederick William Micronised fat particles
BR0210680A (pt) * 2001-07-18 2004-09-21 Dsm Ip Assets Bv Processo para a hidrólise de proteìnas do leite
DE10145818C1 (de) 2001-09-17 2002-10-10 Alfill Engineering Gmbh & Co K Sterilisiervorrichtung mit H202-Verdampfer
DE10146594A1 (de) 2001-09-21 2003-04-10 Solvay Interox Gmbh Stabilisiertes Wasserstoffperoxid
GB2381451A (en) 2001-11-01 2003-05-07 New Technology Res Ltd Pharmaco-dietary preparation having nutrition-supplementing and nutrition-enhancing effect
JP2003137790A (ja) 2001-11-01 2003-05-14 Mie Kariyou Kk β−2,1(β2→β1)結合連鎖フラクトースオリゴマーを含有するフラクトオリゴ糖を有効成分とする医薬
ES2291406T3 (es) * 2001-11-26 2008-03-01 Nestec S.A. Composicion nutritiva auto-estable, que contiene proteina de suero lacteo, intacta, procedimiento de fabricacion y uso.
EP2239028A1 (en) 2001-12-12 2010-10-13 Martek Biosciences Corporation Extraction and Winterization of Lipids From Oilseed and Microbial Sources
US6811801B2 (en) 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
US7168581B2 (en) 2001-12-21 2007-01-30 Rexam Medical Packaging Inc. Closure for a retort processed container having a peelable seal
DE10163676A1 (de) 2001-12-21 2003-07-10 Phenion Gmbh & Co Kg Verwendung von Hyperforin oder Extrakten aus Johanniskraut gegen anaphylaktische Schockzustände oder Osteoporose
JP4497930B2 (ja) 2002-04-23 2010-07-07 アベンティス・ファーマスーティカルズ・インコーポレイテツド インターロイキン−4遺伝子発現抑制剤としての3−置換アミノ−1H−インドール−2−カルボン酸および3−置換アミノ−ベンゾ(b)チオフェン−2−カルボン酸誘導体
SE0201581D0 (sv) 2002-05-29 2002-05-29 Scandinavian Biotechnology Res New improved acyltransferase
WO2004002232A1 (en) 2002-06-28 2004-01-08 Theuer Richard C Fat compositions for infant formula and methods therefor
US20040220266A1 (en) * 2002-09-09 2004-11-04 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040048925A1 (en) 2002-09-09 2004-03-11 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040106678A1 (en) 2002-09-17 2004-06-03 Dobbins Thomas A Compositions for the parenteral administration of calcium and magnesium
US7411039B2 (en) 2002-10-14 2008-08-12 Novo Nordisk A/S GLP-2 compounds, formulations, and uses thereof
US7445807B2 (en) 2002-10-15 2008-11-04 Western Holdings, Llc Agglomerated granular protein-rich nutritional supplement
CN1307478C (zh) 2003-01-07 2007-03-28 统宝光电股份有限公司 降低反射的液晶显示单元构造及其形成方法
GB0301554D0 (en) 2003-01-23 2003-02-26 Molecularnature Ltd Immunostimulatory compositions
US7332178B2 (en) 2003-04-25 2008-02-19 Abbott Laboratories Stable nutritional powder containing ascorbyl palmitate
FR2856596B1 (fr) 2003-06-27 2007-04-27 Bioprojet Soc Civ Nouvelle association medicamenteuse psychiatrique et utilisation d'une antagoniste ou agoniste inverse du recepteur h3 de l'histamine pour preparer un medicament prevenant des effets indesirables de psychotropes.
WO2005035557A2 (en) 2003-10-14 2005-04-21 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Adenylate cyclase in the treatment and/or prophylaxis of immune-medicated disease
IL158555A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Human breast milk lipid mimetic as dietary supplement
ES2314485T3 (es) 2003-12-24 2009-03-16 N.V. Nutricia Composiciones que comprenden acido pantotenico o derivados del mismo y su uso para estimular el apetito.
WO2005096846A1 (en) * 2004-03-11 2005-10-20 Wiley Organics, Inc. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20050215640A1 (en) * 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
US20050249650A1 (en) 2004-05-07 2005-11-10 Fmc Technologies, Inc. Immersion retort
DE102004036047A1 (de) 2004-07-24 2006-02-23 Bioghurt Biogarde Gmbh & Co. Kg Physiologisch aktive Zusammensetzung
US20060024385A1 (en) 2004-07-27 2006-02-02 Pedersen Mark A Metabolic capacity enhancing compositions and methods for use in a mammal
EP1799052B2 (en) 2004-09-09 2020-01-08 Société des Produits Nestlé S.A. Methods for the manufacture of nutritional products having improved quality
WO2006031699A2 (en) 2004-09-10 2006-03-23 Diversa Corporation Compositions and methods for making and modifying oils
JP4262710B2 (ja) 2004-10-15 2009-05-13 株式会社大塚製薬工場 流動食の製造方法
PL371081A1 (pl) 2004-11-08 2006-05-15 Sgp & Sons Ab Preparat farmaceutyczny wpływający na procesy wzrostu i mineralizacji układu kostno-szkieletowego oraz chorób kości i chrząstki wieku dojrzałego u ludzi i zwierząt oraz zastosowanie preparatu farmaceutycznego w procesie wzrostu i mineralizacji układu kostno-szkieletowego oraz chorób kości i chrząstki wieku dojrzałego u ludzi i zwierząt
WO2006058083A2 (en) * 2004-11-24 2006-06-01 Cornell Research Foundation, Inc. Protein and calcium fortification system for clear and opaque beverages
US8067052B2 (en) 2005-02-25 2011-11-29 Siddharth Shastri Nutritional composition and a container for the convenient transport and storage of the nutritional composition
CA2537452C (en) 2005-03-09 2013-12-24 Abbott Laboratories Concentrated human milk fortifier liquid
CN101198261B (zh) 2005-04-27 2013-05-15 恩兹默泰克有限公司 人乳脂替代品
MX2007013028A (es) 2005-06-06 2008-01-11 Bristol Myers Squibb Co Formulas infantiles con bajo contenido de fitato.
BRPI0615396A2 (pt) * 2005-08-26 2011-05-17 Nestec Sa composição nutricional para a prevenção ou tratamento de má-nutrição em um paciente obeso, bem como uso de uma fonte de proteìna, vitamina a, vitamina c, vitamina e, zinco e selênio para sua preparação
EP1762147A1 (en) 2005-09-09 2007-03-14 Primalac Private Foundation Nutritional concentrate for infants
MY147363A (en) 2005-09-20 2012-11-30 Nestec Sa Water dispersible composition and method for preparing same
US20090182050A1 (en) 2005-10-07 2009-07-16 Ocean Nutrition Canada, Ltd. Salts of Fatty Acids and Methods of Making and Using thereof
EP1973426A2 (en) 2005-11-03 2008-10-01 Southwest Immunology Inc. Compositions for preventing and reducing delayed onset muscle soreness
WO2007075605A2 (en) * 2005-12-19 2007-07-05 Abbott Laboratories Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type and type 2 cytokine production
US20090087540A1 (en) 2006-01-31 2009-04-02 Nestec S.A. Nutritional composition for low birth weight infants
US20070219146A1 (en) 2006-02-06 2007-09-20 Sunil Bhaskaran Synergistic Pharmaceutical And/Or Neutraceutical Flavanoid Composition For Management Of Diabetes Mellitus
KR20080098616A (ko) 2006-02-21 2008-11-11 뉴트리조이, 인크. 향상된 맛을 지닌 단백질 함유 식품 또는 음료를 제조하기 위한 조성 및 제조 방법 및 칼슘과 미량 광물질로 영양 보충된 과일 주스
BRPI0712187A2 (pt) 2006-06-05 2012-03-06 Liqui-Box Canada Inc. processo e aparelho para formar uma bolsa de espaÇo confinado mÍnimo
JP2009539392A (ja) * 2006-06-12 2009-11-19 ネステク ソシエテ アノニム 酸乳系飲料を調製するための長期保存可能な乳濃縮物
US20080119552A1 (en) 2006-11-17 2008-05-22 Novus International Inc. Matrix-embedded compositions having organic acids and fatty acids
US20080194407A1 (en) * 2007-02-14 2008-08-14 Ashmead H Dewayne High nitrogen containing chelate compositions suitable for plant delivery
MX2009009996A (es) 2007-03-19 2010-01-20 Atm Metabolics Lllp Composicion y metodo para tratar diabetes y trastornos metabolicos.
US20090110674A1 (en) * 2007-10-24 2009-04-30 Loizou Nicos C Health supplement
US8029830B2 (en) 2008-04-18 2011-10-04 Nuvocare Health Services Inc. Composition and method for promoting internal health and external appearance
CN101574146B (zh) 2008-05-07 2012-06-13 北京康比特体育科技股份有限公司 一种含有hmb的运动营养补剂
CA2723441A1 (en) 2008-05-21 2009-11-26 Stokely-Van Camp, Inc. Milk-based recovery beverage
US20100074969A1 (en) 2008-09-19 2010-03-25 Unicity International, Inc. Method of controlling blood sugar levels, insulin levels, cholesterol levels, body fat levels, and body weight by administering a nutrient fiber matrix
ES2689700T3 (es) * 2008-12-09 2018-11-15 Metabolic Technologies, Inc. Intervención nutricional para mejorar la función y resistencia muscular
JP2009155336A (ja) 2009-03-31 2009-07-16 Tsujido Chemical Corp 治療剤
JP2009159983A (ja) * 2009-04-13 2009-07-23 Tsujido Chemical Corp 食品組成物
CN101569412B (zh) 2009-06-01 2012-12-05 北京康比特体育科技股份有限公司 一种运动营养补剂及其应用
US20090312419A1 (en) * 2009-08-12 2009-12-17 Kneller Bruce W CREATINE -ßALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE
CN101703246A (zh) 2009-11-17 2010-05-12 卢惠强 一种运动补充组合物
PL217815B1 (pl) 2009-12-14 2014-08-29 Olimp Lab Spółka Z Ograniczoną Odpowiedzialnością Napój izotoniczny z chelatami
JP5892948B2 (ja) 2010-01-29 2016-03-23 アボット・ラボラトリーズAbbott Laboratories カルシウムhmbを含む栄養エマルジョン
SG182807A1 (en) 2010-01-29 2012-09-27 Abbott Lab Plastic packaged nutritonal liquids comprising hmb
PE20121728A1 (es) 2010-01-29 2013-01-13 Abbott Lab Polvos nutricionales que comprenden hmb secado por aspersion
CN102711525B (zh) 2010-01-29 2015-03-11 雅培制药有限公司 包含hmb钙和可溶蛋白的营养乳液
RU2012125878A (ru) 2010-01-29 2014-03-10 Эбботт Лэборетриз Асептически упакованные питательные жидкости, содержащие бета-гидрокси-бета-метилбутират (гмб)
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣hmb及可溶性蛋白質之實質上透明營養液
CA2821725A1 (en) 2010-12-22 2012-06-28 Abbott Laboratories Nutritional products comprising calcium beta-hydroxy-beta methylbutyrate and conjugated linoleic acid
WO2012097064A1 (en) 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for controlling blood glucose
ES2689225T3 (es) 2011-02-07 2018-11-12 Abbott Laboratories Productos nutricionales que comprenden beta-hidroxi-beta-metilbutirato
US9326956B2 (en) 2011-02-17 2016-05-03 Abbott Laboratories Methods for improving brain development and cognitive function using beta-hydroxy-beta methylbutyrate
CA2737972A1 (en) 2011-04-07 2012-10-07 Abbott Laboratories Aseptically packaged nutritional concentrate

Similar Documents

Publication Publication Date Title
JP2013528060A5 (ja)
MX2018009230A (es) Formulaciones nutritivas que comprenden un aislado de proteina de guisante.
JP2013172741A5 (ja)
JP2013224310A5 (ja)
WO2011003015A8 (en) Nutritional supplement
MY182593A (en) Composition containing chitin and digestible proteins
RU2012139658A (ru) Композиции и способы для доставки питательных веществ
NZ700686A (en) Uses of casein compositions
WO2011069042A3 (en) Nutritional formulation comprising a cow's milk peptide-containing hydrolysate and/or peptides derived thereof for tolerance induction
MY155534A (en) Enteral nutrient
AR073234A1 (es) Precarga de proteina de suero.
PH12014502288A1 (en) Ready to drink beverages and methods of making thereof
MX2016000187A (es) Composiciones y metodos para mejorar el rendimiento del ejercicio.
MY171322A (en) Dosing protocols for increasing protein synthesis in an active individual
JP2010275318A5 (ja)
MX2020005867A (es) Producto alimenticio para mascotas.
PH12015502308A1 (en) Nutritional composition comprising whey and hydrolyzed casein and uses thereof
GB2510712A (en) Nutritional product comprising a biguanide
CN102232596A (zh) 一种补锌饮料
WO2014153381A8 (en) Alpha-lactalbumin enriched whey protein compositions and methods of making and using them
WO2013004865A3 (es) Suplemento alimenticio, método para incrementar la masa bacteriana en el rumen de un rumiante y preparado alimenticio y usos correspondientes
WO2015095570A3 (en) Nutritional composition comprising hydrolyzed protein
AU2015100838A4 (en) Nutritional Icy Pole (aka freezie, popsicle etc)
Ali et al. Characterization and Functional Properties of Watermelon (Citrullus lanatus) Seed Protein Isolates and Salt Assisted Protein Concentrates
CN103637200A (zh) 一种胶原蛋白营养液